Hospice News March 16, 2020
Staff

During the last several years, the hospice mergers and acquisitions market has luxuriated in an upsurge in volume and valuations. The market strength displayed throughout 2016-2018 continued through the boom quarters of 2019, and the M&A advisory firms’ outlook for 2020 was positive.

As 2019 closed, however, the firms’ partners could not have anticipated the rapid growth and potential impact of the COVID-19 pandemic. As firms now gear up, taking steps to protect their patients, staff, operations, and bottom lines, they must also face the question of how changing economic conditions may affect the still-flourishing M&A market.

Mark Kulik, managing director of The Braff Group, said the impact of COVID-19 on the hospice/home health M&A business depends on how long...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Post-Acute Care, Provider, Trends
VITAS Closes $85M Covenant Health Transaction
‘We’re Seeing Tons Of Opportunity’: Home-Based Care Buyers Deploy DIY M&A, Earnout Structures In 2024 Dealmaking Strategies
Movers and Shakers: LifeLoop Names CEO; United Group Promotes Two C-Suite Roles
Kids’ book illustrates ‘unseen’ long-term care conversation for a new generation
Lawmakers pump brakes on proposed HCBS funding boost

Share This Article